Alzheimer's disease
| 8 min read
New gene therapies in clinical trials seek to treat Alzheimer’s disease and heal the brain with a dose of helpful genetic material.
| 3 min read
By watching brain organoids develop, researchers observed surprising abnormalities caused by mutations in a gene related to early-onset Alzheimer’s disease.
| 10+ min read
Explore the science behind young blood transfusion and blood rejuvenation therapy. Learn how researchers are studying the potential of young plasma to reverse the effects of aging.
| 3 min read
Activating specific neurons using light helped scientists establish a causal link between improved sleep and diminished signs of Alzheimer’s disease in mice.
Available on Demand
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
| 3 min read
A small molecule called ALGERNON2 improved health outcomes in mouse models of neurodegenerative diseases by activating antioxidant pathways in astrocytes.
| 2 min read
A dementia-associated tau mutation promotes unusual clustering of Fyn, a protein important for learning and memory.
| 4 min read
A collaboration of nephrologists and biochemists created the first structure of “megalin,” a critical protein in kidney and brain disorders.
| 4 min read
By analyzing the changing genomes of short- and long-lived rockfish, scientists identified a new set of genes that might alter lifespan.
| 10+ min read
Drugs that target senescent cells could one day treat frailty, Alzheimer’s disease, or cancer.
